Search

everythinglearnresearchcommunity

for

Search:↓

Trichodysplasia spinulosa is a rare skin condition linked to weakened immune systems, mostly in organ transplant patients.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Certain chemotherapy drugs can cause permanent hair loss in stem cell transplant patients.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

HIV patients in Korea often have skin diseases like fungal infections, folliculitis, and seborrheic dermatitis, which are less common with effective HIV treatment.

Blocking certain proteins on immune cells may help treat alopecia areata.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

The immune system can cause permanent skin and hair whitening by attacking pigment cells.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Enhancing Tregs can protect against alopecia areata.

The treatment improved hair color in most vitiligo patients without major side effects.

Cyclosporine combined with other treatments can help hair regrow in severe alopecia areata, but it may cause side effects.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Skin ulcers from interferon may not depend on the amount given.

Anti-CD19 therapy may help treat SLE and NMOSD.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

A kidney transplant patient developed pink skin bumps with spiny centers on her face and limbs.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.